Payoneer Global Inc. (PAYO)
Whether directors and officers of Payoneer Global Inc. (PAYO) breached their fiduciary duties to the company and its shareholders.
Investigation
06/17/2021
Initial Lawsuit
06/17/2021
Lawsuit Progression
08/17/2021
Investigation regarding Ocugen’s biologics license application (BLA) with the U.S. Food and Drug Administration (FDA) instead of an Emergency Use Authorization (EUA) for COVAXIN.
06/10/2021
Ocugen announces that “upon recommendation from the U.S. Food and Drug Administration (FDA), it will pursue submission of a biologics license application (BLA) for its COVID-19 vaccine candidate, COVAXIN™” and “no longer pursue an Emergency Use Authorization (EUA) for COVAXIN™“.
“The FDA provided feedback to Ocugen regarding the Master File the Company had previously submitted and recommended that Ocugen pursue a BLA submission instead of an EUA application for its vaccine candidate and requested additional information and data. Ocugen is in discussions with the FDA to understand the additional information required to support a BLA submission. The Company anticipates that data from an additional clinical trial will be required to support the submission.”
Stock Impact
Close | Previous close | Price variation | Percentage variation |
---|---|---|---|
$6.69 | $9.31 | $-2.62 | -28.14% |
This is a federal securities class action on behalf of a class consisting of all persons who purchased or otherwise acquired Ocugen securities between February 2, 2021, and June 10,2021, inclusive.
According to the complaint, defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the company’s business, operations, and prospects. Specifically, defendants allegedly failed to disclose to investors that:
(i) deceived the investing public regarding Ocugen’s business, operations, management, and the intrinsic value of its securities and
(ii) caused Plaintiff and other shareholders to purchase Ocugen securities at artificially inflated prices.
The lead plaintiff deadline has passed, we will update this page as the lawsuit progresses.
Last event retrieved on 10/06/2022.
Whether directors and officers of Payoneer Global Inc. (PAYO) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Builders FirstSource, Inc. (BLDR) breached their fiduciary duties to the company and its shareholders.
Confidential investigation: officers & directors’ potential breach of fiduciary duties to investors.
Whether directors and officers of Inari Medical, Inc. (NARI) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Amicus Therapeutics, Inc. (FOLD) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of LegalZoom.com, Inc. (LZ) breached their fiduciary duties to the company and its shareholders.